Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
Moderna(MRNA) stock is priced at $56.32, giving the company a market capitalization of 21.56B. It carries a P/E multiple of -6.67.
On 2026-05-10, Moderna(MRNA) stock moved within a range of $48.78 to $57.78. With shares now at $56.32, the stock is trading +15.5% above its intraday low and -2.5% below the session's peak.
Trading volume for Moderna(MRNA) stock has reached 20.93M, versus its average volume of 7.77M.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $59.55 and a low of $22.28.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $59.55 and a low of $22.28.
MRNA News
Moderna ( (MRNA) ) has risen by 14.90%. Read on to learn why. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful investing tools for smarter, shar...
In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, alongside a net loss of US$1.34 billion and basic...
Bloomberg noted that Moderna said it is conducting early-stage research into vaccines targeting hantaviruses, even as health experts suggest the virus linked to...
Analyst ratings
65%
of 26 ratingsMore MRNA News
Moderna (MRNA) shares are surging 14% at the time of writing as investors react to the hantavirus and the biotech company’s early vaccine work. The virus has be...
Moderna (MRNA) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions D...
Moderna stock is showing upward bias. Where is MRNA stock headed? What To Watch: Moderna’s Flu Vaccine Phase 3 Results Moderna Stock: Key Levels To Watch With p...
Moderna published Phase 3 results for its mRNA-1010 flu vaccine in the New England Journal of Medicine. The mRNA flu vaccine showed higher efficacy compared wi...
Biotech and Pharma Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied In this article MRNA This aerial view shows the cruise ship MV Hondius...
Moderna stock is among today’s top performers. Why is MRNA stock up today? MRNA-1010 Demonstrates Superior Relative Vaccine Efficacy The company said the peer-r...
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $136.15, changing hands for $141.04/shar...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.